Trademark Search
Owners
H. Lee Moffitt Cancer Center and Research Institute, Inc.
MOFFITT CANCER CENTER
on 24 Apr 2024
Last Applicant/ Owned by
12902 Magnolia Drive
Tampa
FL
33612-9497
Serial Number
86214921 filed on 07th Mar 2014
Registration Number
4640131 registered on 18th Nov 2014
Correspondent Address
Corey K. Cho SALIWANCHIK, LLOYD & EISENSCHENK, P.A.
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
Providing an online database and depository for the collection of clinical and molecular data derived from a patient that is accessible by physicians, patients and researchers, namely, an online database in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating Read More
Providing health care, medical information and counseling in the field of cancer; providing medical screening and diagnostic services with use of patient scanning equipment; providing an online computer database featuring medical information in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness; medical services, namely, cancer care and prevention of cancer, and medical diagnostics, prognostics and evaluation of drug and treatment effectiveness relating to cancer and other diseases; medical counseling; telephone hot line counseling, namely, offering advice regarding cancer prevention, detection, treatment and clinical testing in the field of cancer and other diseases
30th Nov 2007
30th Nov 2007
Providing an online database and depository for the collection of clinical and molecular data derived from a patient that is accessible by physicians, patients and researchers, namely, an online database in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases for research purposes; medical and clinical research resources in the field of cancer and other diseases, namely, providing data regarding tumor-specific molecular signatures and the effectiveness of a drug and/or diagnostic test for research purposes; medical and clinical research resources in the field of cancer and other diseases, namely, providing evidence-based treatment protocols by effectively comparing standard treatment therapies with clinical outcomes for research purposes; medical research services consisting of collection and analysis of data in the field of human clinical and molecular data for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases, namely, matching particular patients to a particular drug, treatment, therapy or clinical trial by the specific molecular signature of the patient; collection and analysis of data services in the field of human clinical and molecular data accumulation and analysis for research assistance for medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases, namely, providing objective data in usable form on the effectiveness of a drug or diagnostic test
31st Dec 2007
31st Dec 2007
Medical educational services, namely, conducting lectures, seminars and workshops to health care practitioners, patients and patient caregivers in the field of health care, cancer care and prevention of cancer, and medical diagnostics, prognostics and the evaluation of drug and treatment effectiveness relating to cancer and other diseases
30th Nov 2007
30th Nov 2007
Publications, namely, printed instructional and teaching materials, brochures, pamphlets, bulletins, newsletters and magazines, all in the field of health care, cancer protection, prevention, detection and treatment, medical diagnostics and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases
30th Nov 2007
30th Nov 2007
No 86214921
No Service Mark
No MOF.TM17
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 24th Apr 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| 24th Apr 2024 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| 24th Apr 2024 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| 24th Apr 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 22nd Dec 2023 | TEAS SECTION 8 & 9 RECEIVED |
| 18th Nov 2023 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 28th Mar 2020 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 28th Mar 2020 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 28th Mar 2020 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 31st Jan 2020 | TEAS SECTION 8 & 15 RECEIVED |
